FTC Releases Interim Staff Report on Prescription Drug Middlemen

Federal Trade Commission (FTC)

Jul 9

Written by St. Paul Corner Drug (SPCD)

Report details how prescription drug middleman profit at the expense of patients by inflating drug costs and squeezing Main Street pharmacies

Read the article

PBMsFTCFederal Initiatives

St. Paul Corner Drug (SPCD)

Drug middlemen in the hot seat: Q&A with USC Schaeffer Center’s Erin Trish

What to Do if You’re Overpaying for Prescriptions